Improving the Power to Track Fibrillar Amyloid Pet Measurements and Evaluate Amyloid-Modifying Treatments Using a Cerebral White Matter Reference Region-Of-Interest

Alzheimer's and Dementia - United States
doi 10.1016/j.jalz.2014.07.069
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Using Pittsburgh Compound B for in Vivo PET Imaging of Fibrillar Amyloid-Beta

Advances in Pharmacology
2012English

White Matter Hyperintensity Patterns in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy

Neurology
Neurology
2016English

Quantitative Analysis of [18F]FDDNP PET Using Subcortical White Matter as Reference Region

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Amyloid PET as a Marker of Normal-Appearing White Matter Early Damage in Multiple Sclerosis: Correlation With CSF Β-Amyloid Levels and Brain Volumes

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Non-Fibrillar Components of Amyloid Deposits Mediate the Self-Association and Tangling of Amyloid Fibrils

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Apolipoprotein E, Not Fibrillar -Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging

Journal of Neuroscience
Neuroscience
2012English

White Matter Hyperintensities and the Mediating Role of Cerebral Amyloid Angiopathy in Dominantly-Inherited Alzheimer’s Disease

PLoS ONE
Multidisciplinary
2018English

Non-Fibrillar Oligomeric Amyloid-Β Within Synapses

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Solid State NMR of Fibrillar Beta Amyloid Isoforms

Biophysical Journal
Biophysics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy